Pernix Therapeutics, Inc. Completes Divesture of Non-Core Assets to Breckenridge Pharmaceutical, Inc.

Published: Sep 12, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it had completed the previously disclosed sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.

Help employers find you! Check out all the jobs and post your resume.

Back to news